Литература

Поставить закладку

Miligkos M, Bannuru RR, Alkofide H, Kher SR, Schmid CH, Balk EM. Leukotrienereceptor antagonists versus placebo in the treatment of asthma in adults and adolescents, a systematic review and meta-analysis. Ann Intern Med. 2015;163(10):756–67. doi: 10.7326/M15-1059.
Zhang HP, Jia CE, Lv Y, Gibson PG, Wang G. Montelukast for prevention and treatment of asthma exacerbations in adults: systematic review and meta-analysis. Allergy Asthma Proc. 2014;35(4):278–87. doi: 10.2500/aap.2014.35.3745.
Федеральные клинические рекомендации по диагностике и терапии бронхиальной астмы, пересмотр 2019 г. - [электронный ресурс] http://spulmo.ru/obshchestvo/news/news-812/ (дата обращения 24.06.2020)
GINA 2020. www.ginasthma.org
Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidencebased review. Drugs. 2007;67:887–901. doi: 10.2165/00003495-200767060-00005.
Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61(6):737–42. doi: 10.1111/j.1398-9995.2006.01007.x
Virchow JC, Mehta A, Ljungblad L, Mitfessel H. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. J Asthma. 2010;47:986–93. doi: 10.1080/02770903.2010.494753.
Nwokoro C, Pandya H, Turner S, Eldridge S, Griffiths CJ, Vulliamy T, et al. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Lancet Respir Med. 2014;2(10):796– 803
Hans Bisgaard , David Skoner, Maria L Boza, Carol A Tozzi, Kathleen Newcomb, Theodore F Reiss, Barbara Knorr, Gertrude Noonan. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol. 2009 Jun;44(6):568-79.doi: 10.1002/ppul.21018.
George Philip , Carolyn Hustad, Gertrude Noonan, Marie-Pierre Malice, Alan Ezekowitz, Theodore F Reiss, Barbara Knorr. Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol. 2009 Oct;124(4):691-6.e6.doi: 10.1016/j.jaci.2009.08.010.
George Philip , Carolyn Hustad, Gertrude Noonan, Marie-Pierre Malice, Alan Ezekowitz, Theodore F Reiss, Barbara Knorr. Analysis of behavior-related adverse experiences in clinical trials of Montelukast. J Allergy Clin Immunol. 2009 Oct;124(4):699-706.e8.doi: 10.1016/j.jaci.2009.08.011
Bygdell M, Brunlöf G, Wallerstedt SM, et al. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population. Pharmacoepidemiol Drug Saf 2012; 21: 79–86
Brigitte Benard , Valérie Bastien, Benjamin Vinet , Roger Yang , Maja Krajinovic , Francine M Ducharme Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Eur Respir J. 2017 Aug 17;50(2):1700148. doi: 10.1183/13993003.00148-2017. Print 2017 Aug.
Meindina G Haarman , Florence van Hunsel , Tjalling W de Vries. Adverse drug reactions of montelukast in children and adults. Pharmacol Res Perspect. 2017 Oct;5(5):e00341. doi: 10.1002/prp2.341.
Клинические.рекомендации. Аллергический ринит. Российская ассоциация аллергологов и клинических иммунологов. Национальная медицинская ассоциация оториноларингологов. Союз педиатров России. Пересмотр 2019 (Проект. http://raaci.ru/dat/pdf/allergic_rhinitis-project.pdf)
Broźek J.L., Bousquet J, Agache I., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines – 2016 Revision // J Allergy Clin Immunol. 2017; 140(4): 950-958. 8
Sven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, Barbro Dahlén, Piotr Kuna, Marek Kowalski, William R Lumry, César Picado, Donald D Stevenson, Jean Bousquet, Romain Pauwels, Stephen T Holgate, Aditi Shahane, Ji Zhang, Theodore F Reiss, Andrew Szczeklik. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. J Respir Crit Care Med. 2002 Jan 1;165(1):9-14.doi: 10.1164/ajrccm.165.1.2010080.
Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Immunol. 2006;97:98–104. doi: 10.1016/S1081- 1206(10)61377-4
Peroni DG, Pescollderungg L, Sandri M, Chinellato I, Boner AL, Piacentini GL. Timeeffect of montelukast on protection against exercise-induced bronchoconstriction. Respir Med. 2011;105(12):1790–7. doi: 10.1016/j.rmed.2011.08.007
de Benedictis FM, Del Giudice MM, Forenza N, et al. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J. 2006;28:291–295
Peters-Golden M, Swern A, Bird S, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006 27:495-503.
Sutherland ER, Camargo CA, Jr, Busse WW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc. 2010;31(1):20–25. doi: 10.2500/aap.2010.31.3307.
Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90
Price D, Popov T, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-71.
Информация доступна по ссылке https://www.fda.gov/drugs/drug-safety-andavailability/fda-requires-boxed-warning-about-serious-mental-health-side-effectsasthma-and-allergy-drug
Marschallinger J, Schäffner I, Klein B, Gelfert R, Rivera FJ, Illes S, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun 2015;6:8466.
Blackman JA, Gurka MJ. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 2007; 28: 92–99.
Easter G, Sharpe L, Hunt CJ. Systematic review and meta-analysis of anxious and depressive symptoms in caregivers of children with asthma. J Pediatr Psychol 2015; 40: 623–632.
Wallerstedt SM, Brunlöf G, Sundström A, et al. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf 2009; 18: 858–864

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница